Alzheimer's disease: synaptic dysfunction and Aβ

被引:367
|
作者
Shankar, Ganesh M. [1 ,2 ]
Walsh, Dominic M. [3 ]
机构
[1] Harvard Univ, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Lab Neurodegenerat Res, Dublin 4, Ireland
来源
关键词
LONG-TERM POTENTIATION; MILD COGNITIVE IMPAIRMENT; SOLUBLE AMYLOID OLIGOMERS; PROTEIN TRANSGENIC MICE; TG2576 MOUSE MODEL; RAT DENTATE GYRUS; HIPPOCAMPAL-NEURONS; PLAQUE-FORMATION; MOLECULAR-BASIS; IN-VIVO;
D O I
10.1186/1750-1326-4-48
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Synapse loss is an early and invariant feature of Alzheimer's disease (AD) and there is a strong correlation between the extent of synapse loss and the severity of dementia. Accordingly, it has been proposed that synapse loss underlies the memory impairment evident in the early phase of AD and that since plasticity is important for neuronal viability, persistent disruption of plasticity may account for the frank cell loss typical of later phases of the disease. Extensive multi-disciplinary research has implicated the amyloid beta-protein (A beta) in the aetiology of AD and here we review the evidence that non-fibrillar soluble forms of A beta are mediators of synaptic compromise. We also discuss the possible mechanisms of A beta synaptotoxicity and potential targets for therapeutic intervention.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease
    Guo, Lan
    Tian, Jing
    Du, Heng
    JOURNAL OF ALZHEIMERS DISEASE, 2017, 57 (04) : 1071 - 1086
  • [22] The contribution of glia to synaptic dysfunction at the onset of Alzheimer's disease
    Kater, M. S. J.
    Smit, A. B.
    Verheijen, M. H. G.
    GLIA, 2019, 67 : E350 - E350
  • [23] Microbiota in neuroinflammation and synaptic dysfunction: a focus on Alzheimer's disease
    Bairamian, Diane
    Sha, Sha
    Rolhion, Nathalie
    Sokol, Harry
    Dorothee, Guillaume
    Lemere, Cynthia A.
    Krantic, Slavica
    MOLECULAR NEURODEGENERATION, 2022, 17 (01)
  • [24] The role of genetic risk factors of Alzheimer's disease in synaptic dysfunction
    Fu, Wing-Yu
    Ip, Nancy Y.
    SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY, 2023, 139 : 3 - 12
  • [25] Synaptic dysfunction and oxidative stress in Alzheimer's disease: Emerging mechanisms
    Forero, D. A.
    Casadesus, G.
    Perry, G.
    Arboleda, H.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2006, 10 (03) : 796 - 805
  • [26] Circuitry and Synaptic Dysfunction in Alzheimer's Disease: A New Tau Hypothesis
    Mondragon-Rodriguez, Siddhartha
    Salgado-Burgos, Humberto
    Pena-Ortega, Fernando
    NEURAL PLASTICITY, 2020, 2020
  • [27] Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
    Nilsson, Johanna
    Gobom, Johan
    Sjodin, Simon
    Brinkmalm, Gunnar
    Ashton, Nicholas J.
    Svensson, Johan
    Johansson, Per
    Portelius, Erik
    Zetterberg, Henrik
    Blennow, Kaj
    Brinkmalm, Ann
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2021, 13 (01)
  • [28] Network dysfunction in Alzheimer's disease: does synaptic scaling drive disease progression?
    Small, David H.
    TRENDS IN MOLECULAR MEDICINE, 2008, 14 (03) : 103 - 108
  • [29] Transcriptomics Study of Neurodegenerative Disease: Emphasis on Synaptic Dysfunction Mechanism in Alzheimer's Disease
    Karim, Sajjad
    Mirza, Zeenat
    Ansari, Shakeel A.
    Rasool, Mahmood
    Iqbal, Zafar
    Sohrab, Sayed S.
    Kamal, Mohammad A.
    Abuzenadah, Adel M.
    Al-Qahtani, Mohammed H.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (07) : 1202 - 1212
  • [30] A synapsin I cleavage fragment contributes to synaptic dysfunction in Alzheimer's disease
    Meng, Lanxia
    Zou, Li
    Xiong, Min
    Chen, Jiehui
    Zhang, Xingyu
    Yu, Ting
    Li, Yiming
    Liu, Congcong
    Chen, Guiqin
    Wang, Zhihao
    Ye, Keqiang
    Zhang, Zhentao
    AGING CELL, 2022, 21 (05)